Inpharma Weekly

, Volume 933, Issue 1, pp 7–8 | Cite as

Risperidone

does it give ‘enough bang for the buck’?
  • Greg L Plosker
Newsletter Article

Abstract

Risperidone is expensive but, apparently, not too expensive. Recent Canadian guidelines suggest a cut-off point for how much spending can be justified per quality-adjusted life-year (QALY) gained when comparing old treatments with new. And a recent cost-utility study conducted by Janssen researchers has determined that risperidone comes close enough to this cut-off point to be recommended as treatment for schizophrenia. The results of this study were discussed at the 20th Annual Canadian Society of Hospital Pharmacists (Western Branches) [Banff, Alberta, Canada; March 1994].

Keywords

Schizophrenia Haloperidol Clozapine Risperidone Antipsychotic Agent 

Copyright information

© Adis International Ltd 1994

Authors and Affiliations

  • Greg L Plosker

There are no affiliations available

Personalised recommendations